G83-26350-78882
4 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 100 / NY
- Registered
- 2021-10-24
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
WEL-31471-21718
Child or adolescent in my care · Female · 2022-06-22
Timeline
-
2021-03-08
Dose 1 — Pfizer-BioNTech
-
2021-03-29
Dose 2 — Pfizer-BioNTech
-
2021-10-14
Dose 3 — Pfizer-BioNTech
-
2021-10-24
Registered in v-safe
- 2021-10-24
- 2021-10-28
- 2021-11-11
- 2021-11-20
- 2021-11-27
-
2022-01-13
Survey response — 3 months, dose 3MedDRA: Oropharyngeal pain — Feeling: Good · Be unable to work or attend schoolFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-09-22
Dose 4 — Moderna
- 2022-10-14
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-12-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | No |
| 2 | 2021-03-29 | Pfizer-BioNTech | No |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
| 4 | 2022-09-22 | Moderna | No |
Free text
Release 10 — 3 months, dose 3
Symptoms: Sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release